The 6 th course is scheduled October 15-23, 2022

Director

Scientific advisors

Institut Pasteur, France
McMaster University, Canada
Harvard Medical School, USA

Scientific committee

University of Warwick, UK
Harvard Medical School, USA
CARB-X, USA
Uppsala University, Sweden
Boehringer Ingelheim, USA
Walter Reed Army Institute of Research, USA
Harvard Medical School, USA
Harvard University, USA
Beat the Reaper LLC, USA
F2G Ltd., UK
University of Bonn, Germany
Genentech / Roche, USA
Center for Anti-Infective Agents, Vienna, Austria

Organising committee

Institut Pasteur, France
Fondation Mérieux, France

Core faculty 2021

D. Andes, University of Wisconsin, USA
B. Bechinger, Strasbourg U., France
A. van Belkum, bioMerieux, France
H. Boucher, Tufts Medical Center, USA
S. Brisse, Institut Pasteur, France
E. Brown, McMaster University, Canada
L. Burrows, McMaster University, Canada
R. Canton, Hospital Ramon y Cajal, Spain
G. Challis, University of Warwick, UK
J.P. Charrier, bioMerieux, France
J.-F. Collet, Université de Louvain, Belgique
P. Courvalin, Institut Pasteur, France
G. Cox, University of Guelph, Canada
L. Debarbieux, Institut Pasteur, France
J.-D. Docquier, University of Siena, Italy
E. Duffy, CARB-X, USA
M. Fisher, St Georges University, UK
M. Gilmore, Harvard Medical School, USA
Y. Grad, Harvard Medical School, USA
Canton, Hospital Ramon y Cajal, Spain
G. Challis, University of Warwick, UK
J.P. Charrier, bioMerieux, France
A. van Belkum, bioMerieux, France
J.-F. Collet, Université de Louvain, Belgique
G. Cox, University of Guelph, Canada
L. Debarbieux, Institut Pasteur, France
J.-D. Docquier, University of Siena, Italy

E. Duffy, CARB-X, USA
M. Fisher, St Georges University, UK
M. Gilmore, Harvard Medical School, USA
Y. Grad, Harvard Medical School, USA
L. Hall-Stoodley, Ohio State University, USA
S. Harbarth, Hopitaux de Genève, Switzerland
D. Hughes, Uppsala University, Sweden
F. Lebreton, Army Institute of Resarch, USA
S. Lory, Harvard Medical School, USA
B. Luisi, University of Cambridge, UK
A. Mankin, University of Illinois, USA
H. Moser, Novartis, USA
A. Myers, Harvard University, USA
K. Outterson, CARB-X, USA
E. Pamer, University of Chicago, USA
R. Patel, Mayo Clinic, USA
M. Pinho, Universidad Nova de Lisboa, Portugal
S. Projan, Beat the Reaper LLC, USA
J. Rex, F2G, UK
C. Sadler, Apconix, UK
H.-G. Sahl, University of Bonn, Germany
J. Steenbergen, Consulting, USA
M.-W. Tan, Genentech/Roche, USA
U. Theuretzbacher, CAIA, Austria
M. Vazquez-Laslop, University of Illinois, USA
G. Wright, McMaster University, Canada

Scroll to Top